Diagnostic imaging plays a crucial role in evaluating obesity-related conditions and monitoring results after weight loss interventions, especially with the rise of GLP-1 agonist use. Advances in imaging biomarkers are enhancing the capacity to detect and characterize metabolic disorders. Artificial intelligence tools now enable automated assessments of body composition, showcasing the potential of whole-body MRI for comprehensive, precise evaluations in patients with obesity. As these technologies evolve, they promise to address long-standing challenges and improve personalized care for this rapidly growing patient cohort . To read more....
Click Here ##Reference## Tordjman M, Fayad ZA, Benzinger TLS, et al. Imaging in patients with obesity: challenges, applications and future directions. Nat Rev Endocrinol. Published online August 8, 2025. doi:10.1038/s41574-025-01166-0## In your…
